SHANGHAI PHARMACEUTICALS HOLDING CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 2607 for the last quarter is 74.56 B HKD, and it's 2.02% lower compared to the previous quarter. The net income of Q2 24 is 1.51 B HKD.